Spatiotemporally Responsive BEC Nanoplatform Targets Neutrophils to Reprogram Immune Crosstalk and Alleviate Periodontal Inflamm‐Ageing in Periodontitis
Journal of Clinical Periodontology · 2026-07 · 53 (7) · 1031-1045
DOI: 10.1111/jcpe.70133 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Periodontology, online erschienen am 04.05.2026. Verfasst von Jiaxin Luo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling, Hospital of Stomatology, Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Neutrophils, Periodontitis, Catechin, Copper. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jilin Province.
Abstract (Originalsprache)
Aim
To investigate the underlying mechanism of immune cell crosstalk in periodontal inflammatory ageing and to explore potential pharmaceutical interventions for safely reversing this process. Materials and Methods Bovine serum albumin–epigallocatechin gallate–copper nanoparticles (BEC NPs) were synthesised by coating a bovine serum albumin membrane onto an epigallocatechin gallate–copper–phenolic network. BEC NPs' regulatory impacts on the fate of neutrophils and macrophages were evaluated through immunofluorescence staining, PCR, RNA sequencing and Western blot analysis. Their anti‐senescence effects on gingival fibroblasts were assessed using cell migration assays and SA‐β‐gal staining, while an experimental periodontitis rat model was established to validate the in vitro findings.
Results
Accumulating evidence indicated that pH‐responsive nanoparticles alleviated periodontal inflamm‐ageing through modulation of neutrophil–macrophage crosstalk. Functional analyses revealed that BEC NPs suppressed neutrophil extracellular trap formation via dual mechanisms: reactive oxygen species scavenging to sustain mitochondrial integrity, and actin cytoskeleton stabilisation to inhibit nuclear translocation of neutrophil elastase and myeloperoxidase. In vivo assessment demonstrated that BEC NPs exhibited a favourable biosafety profile and significant therapeutic efficacy in suppressing the progression of periodontal inflammation.
Conclusion
This study presents a smart nanosystem‐based ‘endogenous homeostasis reconstruction’ strategy, offering programmable, early‐stage intervention for periodontal inflamm‐ageing with considerable clinical translation prospects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling, Hospital of Stomatology, Jilin University, Changchun, China.
- Department of Oral Implantology, Hospital of Stomatology, Jilin University, Changchun, China.
ORCID-Profile: Yanmin Zhou
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jilin Province
Zitieren
APA
Luo, J., Chen, J., Ren, S., Li, M., Zhai, S., Chen, S., Feng, J., Wang, Z., Wang, H., & Zhou, Y. (2026). Spatiotemporally Responsive BEC Nanoplatform Targets Neutrophils to Reprogram Immune Crosstalk and Alleviate Periodontal Inflamm‐Ageing in Periodontitis. Journal of Clinical Periodontology, 53(7), 1031-1045. https://doi.org/10.1111/jcpe.70133
Vancouver
Luo J, Chen J, Ren S, Li M, Zhai S, Chen S, et al. Spatiotemporally Responsive BEC Nanoplatform Targets Neutrophils to Reprogram Immune Crosstalk and Alleviate Periodontal Inflamm‐Ageing in Periodontitis. Journal of Clinical Periodontology. 2026;53(7):1031-1045. doi:10.1111/jcpe.70133
BibTeX
@article{Luo2026,
author = {Luo, Jiaxin and Chen, Jingxia and Ren, Sicong and Li, Mucong and Zhai, Shaobo and Chen, Sheng and Feng, Jian and Wang, Zhibo and Wang, Hanchi and Zhou, Yanmin},
title = {Spatiotemporally Responsive BEC Nanoplatform Targets Neutrophils to Reprogram Immune Crosstalk and Alleviate Periodontal Inflamm‐Ageing in Periodontitis},
journal = {Journal of Clinical Periodontology},
year = {2026},
volume = {53},
number = {7},
pages = {1031--1045},
doi = {10.1111/jcpe.70133}
}
EUVIMED